Delivery Order SPE2DE24DA011-SPE2D625F4AXB
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,600.22 for endoscopic spine instrument usage on August 21, 2025. This fixed-price delivery order with economic price adjustment represents work under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at approximately $471 million and extending through September 1, 2029. The...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $4,265.22 on August 21, 2025, for endoscopic spine instrument usage. The contract, which carries no set-aside designation, was issued by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 3, 2025. Performance will occur in Naples, FL. This delivery order falls under Arthrex's larger Indefinite Delivery Contract...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $4,260.22 fixed-price delivery order with economic price adjustment on August 21, 2025, for endoscopic spine instrument usage. The contract, which carries no set-aside designation, is scheduled for completion by September 3, 2025, and will be performed in Naples, Florida. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, reflecting the Department of...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,618.96 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by July 23, 2025, and will be performed in Naples, FL. This award was issued without a set-aside designation, reflecting Arthrex's strong competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $56,896.19 on September 8, 2025, with completion targeted for September 22, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $1,101.65 on August 15, 2025, for C-line endoscopic soft tissue release instruments. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of August 20, 2025. The award carries no set-aside designation, reflecting Arthrex's...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a $4,595.22 delivery order to Arthrex Inc. for endoscopic spine instrument usage. This fixed-price delivery order with economic price adjustment was issued on August 25, 2025, with an ultimate completion date of August 29, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The work will be performed in Naples, Florida, where...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,369.50 on August 19, 2025, with an ultimate completion date of August 22, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and supplies to the Department of Defense and Veterans Affairs...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,557.20 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This fixed-price contract with economic price adjustment provisions is designated as a System Implementation Quadrilateral 9MM 1S and will be performed in Naples, Florida, with an ultimate completion date of August 21, 2025. The award is not set aside for any specific business...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,246.07 on May 20, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by May 28, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D625F4AXBDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,600.22 on August 25, 2025, for endoscopic spine instrument usage. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by September 26, 2025, and will be performed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which serves the Department of Defense healthcare enterprise. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471 billion vehicle running from June 2024 through September 2029 that enables VA medical centers nationwide to access Arthrex's comprehensive portfolio of orthopedic surgical technologies. The endoscopic spine instruments represent part of Arthrex's specialized surgical instrument systems designed to support advanced orthopedic procedures across the federal healthcare system, with the company having already accumulated over $550,000 in delivery orders under this IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/25/25 |